Comparison of laparoscopic totally extraperitoneal repair with adjunct techniques and open surgery (TREPP) in female patients with incarcerated femoral hernia: a single-center retrospective cohort study

腹腔镜下完全腹膜外修补术联合辅助技术与开放手术(TREPP)治疗女性嵌顿性股疝的比较:一项单中心回顾性队列研究

阅读:1

Abstract

BACKGROUND: Incarcerated femoral hernia often requires urgent surgical intervention, yet the optimal approach remains debated. Open surgery—particularly the transrectus sheath preperitoneal procedure (TREPP)—is commonly used, while laparoscopic totally extraperitoneal (TEP) repair is gaining traction. This study aimed to evaluate the clinical outcomes of laparoscopic TEP with adjunct techniques (aTEP) versus TREPP in female patients with incarcerated femoral hernia. METHODS: This was a single-centre, retrospective, comparative study conducted at the Shenzhen People’s Hospital between January 2020 and December 2023. Female patients with incarcerated femoral hernias who underwent either aTEP or TREPP were included. The aTEP technique involved a standard laparoscopic TEP repair with the addition of a small femoral ring incision, and final laparoscopic observation through the umbilicus to assess bowel viability. Surgical approach was determined based on clinical presentation, patient condition, and surgeon judgment. Baseline characteristics and intra-/postoperative outcomes were compared between groups. RESULTS: The study included 42 patients, with 22 in the TREPP group and 20 in the aTEP group. The aTEP group demonstrated significantly better outcomes in several metrics, including shorter operative time, less intraoperative hemorrhage, lower pain scores at 24 h and postoperative day 7, reduced analgesic use, and shorter hospital stays. CONCLUSION: Laparoscopic TEP, when supplemented with selective adjunct techniques, is a safe and effective surgical option for incarcerated femoral hernias in females. Compared with TREPP, it offers improved perioperative outcomes and faster recovery, particularly in patients without severe bowel compromise. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。